News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MorphoSys AG Signs Cross License Deal With Eli Lilly and Company (LLY)



10/19/2005 5:12:41 PM

FRANKFURT, Sept 23 (Reuters) - German biotech firm MorphoSys (MORG.DE: Quote, Profile, Research) on Friday announced a cross licence agreement with Eli Lilly (LLY.N: Quote, Profile, Research) as part of a settlement to resolve patent litigation initiated by an Eli Lilly subsidiary.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES